Global Retained Earnings vs Other Stockholder Equity Analysis
| GMRE Stock | USD 8.89 0.03 0.34% |
Global Medical financial indicator trend analysis is much more than just examining Global Medical REIT latest accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Global Medical REIT is a good investment. Please check the relationship between Global Medical Retained Earnings and its Other Stockholder Equity accounts. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Global Medical REIT. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.
Retained Earnings vs Other Stockholder Equity
Retained Earnings vs Other Stockholder Equity Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Global Medical REIT Retained Earnings account and Other Stockholder Equity. At this time, the significance of the direction appears to have pay attention.
The correlation between Global Medical's Retained Earnings and Other Stockholder Equity is -0.97. Overlapping area represents the amount of variation of Retained Earnings that can explain the historical movement of Other Stockholder Equity in the same time period over historical financial statements of Global Medical REIT, assuming nothing else is changed. The correlation between historical values of Global Medical's Retained Earnings and Other Stockholder Equity is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Retained Earnings of Global Medical REIT are associated (or correlated) with its Other Stockholder Equity. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Other Stockholder Equity has no effect on the direction of Retained Earnings i.e., Global Medical's Retained Earnings and Other Stockholder Equity go up and down completely randomly.
Correlation Coefficient | -0.97 |
| Relationship Direction | Negative |
| Relationship Strength | Significant |
Retained Earnings
The cumulative amount of net income that a company retains for reinvestment in its operations, rather than distributing it to shareholders as dividends.Other Stockholder Equity
Most indicators from Global Medical's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Global Medical REIT current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Global Medical REIT. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. At present, Global Medical's Enterprise Value Multiple is projected to increase significantly based on the last few years of reporting. The current year's Enterprise Value is expected to grow to about 18.9 M, whereas Issuance Of Capital Stock is projected to grow to (78.8 K).
| 2021 | 2022 | 2023 | 2024 (projected) | Total Revenue | 115.9M | 137.3M | 140.9M | 71.8M | Depreciation And Amortization | 79.0M | 98.8M | 59.0M | 40.7M |
Global Medical fundamental ratios Correlations
Click cells to compare fundamentals
Global Medical Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Global Medical fundamental ratios Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Total Assets | 884.9M | 1.1B | 1.3B | 1.4B | 1.3B | 1.3B | |
| Other Current Liab | 12.7M | 12.5M | 15.7M | (625.1M) | 11.7M | 12.3M | |
| Total Current Liabilities | 365.3M | 541.4M | 540.6M | 666.1M | 30.0M | 28.5M | |
| Total Stockholder Equity | 430.3M | 444.8M | 622.8M | 633.0M | 583.6M | 612.8M | |
| Net Debt | 383.4M | 581.1M | 564.5M | 690.1M | 616.8M | 647.6M | |
| Retained Earnings | (71.4M) | (116.8M) | (157.0M) | (198.7M) | (239.0M) | (227.0M) | |
| Cash | 2.8M | 5.5M | 7.2M | 4.0M | 1.3M | 1.2M | |
| Cash And Short Term Investments | 2.8M | 5.5M | 7.2M | 4.0M | 26.4M | 27.7M | |
| Common Stock Total Equity | 44K | 49K | 65K | 66K | 75.9K | 79.7K | |
| Liabilities And Stockholders Equity | 884.9M | 1.1B | 1.3B | 1.4B | 1.3B | 1.3B | |
| Other Current Assets | (29.8M) | (41.5M) | (50.3M) | 18.3M | 6.1M | 6.4M | |
| Other Stockholder Equity | 433.3M | 504.8M | 711.4M | 722.0M | 722.4M | 758.5M | |
| Total Liab | 424.6M | 643.1M | 625.9M | 744.2M | 661.9M | 695.0M | |
| Total Current Assets | 15.6M | 21.3M | 24.9M | 30.5M | 67.6M | 71.0M | |
| Common Stock | 44K | 49K | 65K | 66K | 75.9K | 79.7K | |
| Common Stock Shares Outstanding | 33.9M | 46.3M | 60.6M | 65.5M | 65.6M | 68.8M | |
| Net Tangible Assets | 313.9M | 363.9M | 541.9M | 552.1M | 634.9M | 666.7M | |
| Accounts Payable | 5.1M | 7.3M | 10.3M | 13.8M | 12.8M | 13.4M | |
| Retained Earnings Total Equity | (71.4M) | (116.8M) | (157.0M) | (198.7M) | (178.8M) | (169.9M) | |
| Capital Surpluse | 433.3M | 504.8M | 711.4M | 722.0M | 830.3M | 871.8M | |
| Short Long Term Debt Total | 733.7M | 604.7M | 579.5M | 694.1M | 618.9M | 478.8M | |
| Other Liab | 11.2M | 12.6M | 20.4M | 17.5M | 20.1M | 21.1M | |
| Property Plant And Equipment Net | 3.1M | 3.6M | 3.8M | 3.5M | 11.0M | 10.4M | |
| Non Current Assets Total | 869.3M | 1.1B | 1.2B | 1.4B | 1.2B | 783.7M | |
| Non Currrent Assets Other | 793.5M | 971.9M | 1.1B | 1.2B | 1.1B | 644.7M | |
| Other Assets | 18.2M | 985.7M | 1.1B | 1.2B | (1K) | (950.0) | |
| Long Term Debt | 386.2M | 83.0M | 57.2M | 57.7M | 25.9M | 24.6M | |
| Net Receivables | 5.0M | 5.7M | 6.2M | 8.2M | 33.5M | 35.2M | |
| Long Term Debt Total | 386.2M | 83.0M | 65.0M | 57.7M | 66.3M | 63.0M | |
| Non Current Liabilities Total | 59.3M | 101.8M | 85.3M | 78.1M | 631.9M | 663.5M | |
| Property Plant And Equipment Gross | 3.1M | 3.6M | 3.8M | 3.5M | 11.0M | 21.6M | |
| Short Long Term Debt | 6.5M | 521.6M | 514.6M | 636.4M | 585.3M | 614.6M | |
| Accumulated Other Comprehensive Income | (6.7M) | (18.2M) | (6.6M) | 34.7M | 25.1M | 26.4M | |
| Non Current Liabilities Other | 11.9M | 14.4M | 12.2M | 15.0M | 9.0M | 8.1M | |
| Short Term Debt | 347.5M | 521.6M | 514.6M | 636.4M | 405K | 384.8K | |
| Property Plant Equipment | 793.0M | 1.0B | 1.2B | 1.3B | 1.5B | 1.6B | |
| Noncontrolling Interest In Consolidated Entity | 30.1M | 13.0M | 14.8M | 16.1M | 18.5M | 16.1M | |
| Good Will | 29.3M | 36.3M | 59.1M | 5.9M | 5.3M | 5.0M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Global Medical REIT is a strong investment it is important to analyze Global Medical's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Global Medical's future performance. For an informed investment choice regarding Global Stock, refer to the following important reports:Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Global Medical REIT. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.
Is Diversified REITs space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Global Medical. If investors know Global will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Global Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.43) | Dividend Share 0.84 | Earnings Share (0.02) | Revenue Per Share 2.082 | Quarterly Revenue Growth (0.04) |
The market value of Global Medical REIT is measured differently than its book value, which is the value of Global that is recorded on the company's balance sheet. Investors also form their own opinion of Global Medical's value that differs from its market value or its book value, called intrinsic value, which is Global Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Global Medical's market value can be influenced by many factors that don't directly affect Global Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Global Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Global Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Global Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.